SK70897A3 - Salt of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5- -dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester, process for producing the same, their use and pharmaceutical compositions containing the same - Google Patents

Salt of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5- -dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester, process for producing the same, their use and pharmaceutical compositions containing the same Download PDF

Info

Publication number
SK70897A3
SK70897A3 SK708-97A SK70897A SK70897A3 SK 70897 A3 SK70897 A3 SK 70897A3 SK 70897 A SK70897 A SK 70897A SK 70897 A3 SK70897 A3 SK 70897A3
Authority
SK
Slovakia
Prior art keywords
formula
phenyl
methyl
compounds
salts
Prior art date
Application number
SK708-97A
Other languages
English (en)
Slovak (sk)
Inventor
Hans Ulrich Stilz
Gerhard Beck
Manfred Radau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SK70897A3 publication Critical patent/SK70897A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SK708-97A 1996-06-05 1997-06-04 Salt of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5- -dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester, process for producing the same, their use and pharmaceutical compositions containing the same SK70897A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622489A DE19622489A1 (de) 1996-06-05 1996-06-05 Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters

Publications (1)

Publication Number Publication Date
SK70897A3 true SK70897A3 (en) 1999-05-07

Family

ID=7796165

Family Applications (1)

Application Number Title Priority Date Filing Date
SK708-97A SK70897A3 (en) 1996-06-05 1997-06-04 Salt of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5- -dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester, process for producing the same, their use and pharmaceutical compositions containing the same

Country Status (24)

Country Link
US (1) US6294562B1 (no)
EP (1) EP0811616B1 (no)
JP (1) JP4249277B2 (no)
KR (1) KR980002029A (no)
CN (1) CN1104420C (no)
AR (1) AR008993A1 (no)
AT (1) ATE294783T1 (no)
AU (1) AU717106B2 (no)
BR (1) BR9703459A (no)
CA (1) CA2206748C (no)
CZ (1) CZ292672B6 (no)
DE (2) DE19622489A1 (no)
ES (1) ES2241016T3 (no)
HK (1) HK1006359A1 (no)
HR (1) HRP970309B1 (no)
HU (1) HUP9700998A3 (no)
IL (1) IL120984A (no)
MX (1) MX9704128A (no)
NO (1) NO307999B1 (no)
PL (1) PL320355A1 (no)
RU (1) RU2174119C2 (no)
SK (1) SK70897A3 (no)
TR (1) TR199700457A2 (no)
ZA (1) ZA974912B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
RU2319702C2 (ru) * 2003-10-02 2008-03-20 Фармация Энд Апджон Компани Ллс Негигроскопическая кристаллическая малеатная соль 5-[(z)-(5-фтор-2-оксо-1,2-дигидро-3h-индол-3-илиден)метил]-n-[(2s)-2-гидрокси-3-морфолин-4-илпропил]-2,4-диметил-1h-пиррол-3-карбоксамида, фармацевтическая композиция и способ лечения рака
US20090298814A1 (en) * 2005-06-07 2009-12-03 Ramot At Tel Aviv Univeristy Ltd Novel salts of conjugated psychotropic drugs and processes of preparing same
AU2007274583B2 (en) 2006-07-17 2012-11-01 Bar-Ilan University Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
AU2010329440A1 (en) 2009-12-09 2012-08-09 Bar-Ilan University Methods of improving cognitive functions
EP2539857A4 (en) 2010-02-24 2013-07-24 Univ Ramot CRYSTALLINE FORMS OF PERPHENAZINE GABA TRIMESYLATE SALT AND PROCESS FOR PRODUCTION THEREOF
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
AR114489A1 (es) * 2018-04-12 2020-09-09 Morphic Therapeutic Inc ANTAGONISTAS DE LA INTEGRINA a4b7 HUMANA
JP7437495B2 (ja) 2019-10-16 2024-02-22 モーフィック セラピューティック，インコーポレイテッド ヒトインテグリンα４β７の阻害

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4309867A1 (de) 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
DE19515177A1 (de) * 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
NO972506D0 (no) 1997-06-02
HUP9700998A3 (en) 1999-03-01
HRP970309B1 (en) 2002-06-30
ZA974912B (en) 1997-12-05
HK1006359A1 (en) 1999-02-26
MX9704128A (es) 1997-12-31
ES2241016T3 (es) 2005-10-16
PL320355A1 (en) 1997-12-08
NO972506L (no) 1997-12-08
TR199700457A2 (xx) 1997-12-21
EP0811616B1 (de) 2005-05-04
NO307999B1 (no) 2000-07-03
HRP970309A2 (en) 1998-04-30
ATE294783T1 (de) 2005-05-15
DE59712294D1 (de) 2005-06-09
BR9703459A (pt) 1998-10-06
CA2206748A1 (en) 1997-12-05
US6294562B1 (en) 2001-09-25
CZ172997A3 (en) 1997-12-17
CN1174835A (zh) 1998-03-04
RU2174119C2 (ru) 2001-09-27
AU2467497A (en) 1997-12-11
DE19622489A1 (de) 1997-12-11
JP4249277B2 (ja) 2009-04-02
IL120984A (en) 2001-08-26
KR980002029A (ko) 1998-03-30
HU9700998D0 (en) 1997-07-28
EP0811616A1 (de) 1997-12-10
HUP9700998A1 (hu) 1998-03-30
AU717106B2 (en) 2000-03-16
IL120984A0 (en) 1997-11-20
JPH1059948A (ja) 1998-03-03
CA2206748C (en) 2007-05-01
AR008993A1 (es) 2000-03-08
CN1104420C (zh) 2003-04-02
CZ292672B6 (cs) 2003-11-12

Similar Documents

Publication Publication Date Title
EP0729460B1 (de) Substituierte 5-ring-heterocyclen, ihre herstellung und ihre verwendung
DE69912379T2 (de) Antithrombosemittel
EP1653950B1 (en) Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
US6794365B2 (en) Malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them
CZ20012379A3 (cs) Nové deriváty malonové kyseliny, způsoby jejich přípravy, použití a farmaceutické přípravky obsahující tyto deriváty (inhibitory aktivity faktoru Xa)
SK70897A3 (en) Salt of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5- -dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester, process for producing the same, their use and pharmaceutical compositions containing the same
SK17032002A3 (sk) Deriváty (tio)močoviny inhibujúce faktor VIIa, spôsob ich prípravy, farmaceutický prípravok, ktorý ich obsahuje a ich použtiie
JP4272278B2 (ja) ビフェニルスルホニルシアナミド、その製造法および医薬としてのその使用
US20050239860A1 (en) Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
HU225158B1 (en) Pde iv inhibiting 2-(cyanoimino)imidazole derivatives, their use, process for producing them and pharmaceutical compositions containing them
SK286856B6 (sk) N-Guanidinoalkylamidy, spôsob ich prípravy, použitie a farmaceutické prostriedky, ktoré ich obsahujú
EP1016663A1 (en) Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
SK17592001A3 (sk) Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje
EP1635816B1 (en) Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
DE69924527T2 (de) Arylalkanoylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zubereitungen
US5958952A (en) Substituted phenylamindines, medicaments containing these compounds and process for producing them
JP5301441B2 (ja) 新規ヒスチジン誘導体
JPS6059230B2 (ja) 不整脈抑制性フエネチルピペリジン化合物
JP5597400B2 (ja) ヒスチジン誘導体を含有する医薬
Okazaki et al. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives
EP1022268A1 (en) Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
MXPA01006485A (en) Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)